Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of the Restrictive Visiting Policy During the Covid-19 Pandemic on Anxiety, Depression and Post-traumatic Stress Disorder for Relatives of ICU Patients

NCT04430049 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT04430049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04430049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of the Restrictive Visiting Policy During the Covid-19 Pandemic on Anxiety, Depression and Post-traumatic Stress Disorder for Relatives of ICU Patients
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Observational
Overall status
Completed
Start date
June 22, 2020
Completion date
November 9, 2022
Enrollment
811 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, critical illness, family members